Latest Research News
David Klemanski, PsyD, MPH, assistant professor of psychiatry, recently published a paper about a new survey he created alongside colleagues Todd Barnes and Cynthia Bautista to measure patient experience for inpatient psychiatry. The measure itself is part of a larger project of patient experience measures within Psychiatry and Behavioral Health.
- June 13, 2022
Dr. Carolyn Fredericks of Yale School of Medicine talks about what is involved when volunteering for brain research on Alzheimer's disease.
- June 08, 2022
Krysten Bold, PhD, assistant professor of psychiatry, has received an R01 grant from the National Institute on Drug Abuse (NIDA) to study the impact of a menthol flavor ban in cigarettes and e-cigarettes to inform tobacco policy.
- May 11, 2022
Researchers at the Yale Departments of Psychiatry and Neurology found that in patients with Parkinson disease, depression, anxiety, and subjective incompetence are mediators between perceived stress and demoralization.
- May 10, 2022
During sleep, our brains are busy consolidating memories and removing waste to keep our minds sharp. Recent findings from Yale on sleep hygiene and more.
- April 20, 2022Source: Psychopharmacology
Anahita Bassir Nia, MD, assistant professor of psychiatry, and Mohini Ranganathan, MD, associate professor of psychiatry, are first and senior authors, respectively, of a paper in Psychopharmacology that investigated the sex differences in the acute effects of intravenous (IV) delta 9 tetrahydrocannabinol (THC), the main psychoactive compound of cannabis.
- April 11, 2022
Can we predict who will develop Alzheimer’s disease and other dementias? Can we identify biomarkers to predict disease development early? What are the most promising treatment targets?
- March 29, 2022Source: The Journal of Clinical Psychiatry
A new study by Yale researchers found the number and proportion of older adults admitted to SUD treatment facilities increased substantially from 2000 to 2017 and were associated with changes in both population numbers and patient characteristics, especially a relative increase among older adults in cocaine/crack and cannabis use and a relative decrease for use of alcohol and opioids.
- March 15, 2022
Two Yale Psychiatry faculty members were among the winners of the 2022 Paul Wender Best Paper in the Journal of Clinical Psychiatry Award from the American Society of Clinical Psychopharmacology.
- February 15, 2022Source: Molecular
A new study by lead author Sophie Holmes, PhD, Assistant Professor of Psychiatry, investigated whether ketamine produces rapid and sustained antidepressant effects through restoration of lost synaptic connections.